Announced
Completed
China Life Private Equity Investment led a $79m Series A round in Huisheng Biopharmaceutical.
Financials
Transaction Value£62m
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-
Tags
Single Bidder
biopharmaceutical company
Private Equity
Acquisition
Minority
Completed
Venture Capital
China
Private
Friendly
Domestic
Pharmaceuticals
Synopsis
China Life Private Equity Investment, a private equity firm, led a $79m Series A round in Huisheng Biopharmaceutical, a biopharmaceutical company, with participation from Tianjin Grand Flight and Ginkgo Capital.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
No credit card required
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.